Aldeyra Therapeutics, Inc. (ALDX) AI Dilution Summary

Cash was $45,089,786 at 2026-06-30 against estimated monthly burn of $1,529,807. The company's funding facility is an active at-the-market program with Jefferies LLC, authorised to $75,000,000, with $0 sold to date. Dated cash outflows after that date include a $50,000 lease security deposit on 2026-07-28 and a $1,200,000 cash settlement of bonus units dated 2026-08-06.